SACHS BRUCE I
SEC CIK 1197036 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals | Dir | 39.0K | $4.92M | $21.55M | 16 | 2021-08-02 | 2026-08-27 |
Most active insiders at VRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LEIDEN JEFFREY M | Executive COB, Dir | — | $60.94M |
| 2 | Sachdev Amit | EVP Chief Patient, Ext Af Off | — | $28.38M |
| 3 | Kewalramani Reshma | CEO, Pres, Dir | — | $19.74M |
| 4 | Bozic Carmen | EVP, CMO | — | $11.31M |
| 5 | WAGNER CHARLES F JR | EVP, CO, FO | — | $10.78M |
| 6 | Tatsis Ourania | EVP, Chief Reg, Quality Off | — | $6.51M |
| 7 | McKechnie Duncan | EVP, Chief Commercial Off | — | $5.66M |
| 8 | Biller Jonathan | EVP, CLO | — | $4.08M |
| 9 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | — | $3.60M |
| 10 | Bunnage Mark E. | EVP, CSO | — | $3.00M |
| 22 | SACHS BRUCE I | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-31 16:20 | 2026-08-27 | VRTX | Vertex Pharmaceuticals | SACHS BRUCE I | Dir | G - Gift | $0.00 | -6,000 | 39.0K | -13% | $0 | |
| M | 2025-08-07 | 2025-08-06 | VRTX | Vertex Pharmaceuticals | SACHS BRUCE I | Dir | P - Purchase | $389.68 | +5,000 | 45.0K | +12% | +$1.95M |
| D | 2024-08-02 | 2024-08-01 | VRTX | Vertex Pharmaceuticals | SACHS BRUCE I | Dir | M - OptEx | $125.71 | +5,295 | 45.3K | +13% | +$665.6K |
| D | 2024-08-02 | 2024-08-01 | VRTX | Vertex Pharmaceuticals | SACHS BRUCE I | Dir | S - Sale+OE | $508.00 | -5,295 | 40.0K | -12% | -$2.69M |
| D | 2024-05-24 | 2024-05-22 | VRTX | Vertex Pharmaceuticals | SACHS BRUCE I | Dir | M - OptEx | $93.51 | +7,073 | 47.1K | +18% | +$661.4K |
| D | 2024-05-24 | 2024-05-22 | VRTX | Vertex Pharmaceuticals | SACHS BRUCE I | Dir | S - Sale+OE | $448.00 | -7,073 | 40.0K | -15% | -$3.17M |
| D | 2023-11-08 | 2023-11-06 | VRTX | Vertex Pharmaceuticals | SACHS BRUCE I | Dir | S - Sale+OE | $385.00 | -11.2K | 40.0K | -22% | -$4.33M |
| D | 2023-11-08 | 2023-11-06 | VRTX | Vertex Pharmaceuticals | SACHS BRUCE I | Dir | M - OptEx | $127.54 | +11.2K | 51.2K | +28% | +$1.43M |
| DM | 2023-07-18 | 2023-07-17 | VRTX | Vertex Pharmaceuticals | SACHS BRUCE I | Dir | S - Sale+OE | $356.75 | -11.2K | 49.6K | -19% | -$4.01M |
| D | 2023-07-18 | 2023-07-17 | VRTX | Vertex Pharmaceuticals | SACHS BRUCE I | Dir | M - OptEx | $127.54 | +11.2K | 51.2K | +28% | +$1.43M |
| DM | 2023-04-14 | 2023-04-12 | VRTX | Vertex Pharmaceuticals | SACHS BRUCE I | Dir | S - Sale+OE | $326.73 | -21.3K | 59.6K | -26% | -$6.96M |
| D | 2023-04-14 | 2023-04-13 | VRTX | Vertex Pharmaceuticals | SACHS BRUCE I | Dir | G - Gift | $0.00 | -1,210 | 40.0K | -3% | $0 |
| D | 2023-04-14 | 2023-04-12 | VRTX | Vertex Pharmaceuticals | SACHS BRUCE I | Dir | M - OptEx | $72.14 | +21.3K | 62.5K | +52% | +$1.54M |
| D | 2023-02-02 | 2023-01-31 | VRTX | Vertex Pharmaceuticals | SACHS BRUCE I | Dir | M - OptEx | $72.14 | +1,200 | 42.4K | +3% | +$86.6K |
| D | 2023-02-02 | 2023-01-31 | VRTX | Vertex Pharmaceuticals | SACHS BRUCE I | Dir | S - Sale+OE | $325.01 | -1,200 | 41.2K | -3% | -$390.0K |
| 2021-08-04 | 2021-08-02 | VRTX | Vertex Pharmaceuticals | SACHS BRUCE I | Dir | P - Purchase | $197.91 | +15.0K | 41.2K | +57% | +$2.97M |
Purchase Sale Sale after option exercise All abbreviations